New Analysis Examines Role of Conditional Approvals on Access to Promising Oncology Therapies
Read more about New Analysis Examines Role of Conditional Approvals on Access to Promising Oncology Therapies
Improving Our Assessments of Drugs With Companion Diagnostic Tests
Read more about Improving Our Assessments of Drugs With Companion Diagnostic Tests
New Report on Emerging Approaches to Economic Evaluations of Tumour-Agnostic Drugs
Read more about New Report on Emerging Approaches to Economic Evaluations of Tumour-Agnostic Drugs
Featured Reports
Powering evidence-informed drug and health technology decisions for sustainable, world-class health care for all
We are experts at finding, interpreting, and assembling the best available information, and we know that evidence is the foundation of good decision-making.
A National Capital Region’s top employer
We are proud and excited to share that our organization has been named one of the National Capital Region's top employers for 2024.
Latest News
Upcoming Events
An Update on the Development of Newborn Screening Guidance in Canada
Canada’s Drug Agency recognizes the traditional territories, rights, and diversity of all First Nations, Inuit, and Métis communities across Canada. Indigenous Peoples have been, and continue to be, excluded from and harmed by Canada’s health care systems. In the spirit of reconciliation, we are committed to addressing these inequities alongside Indigenous communities.